Literature DB >> 23038655

Double flap technique for reconstruction of anterior skull base defects after craniofacial tumor resection: technical note.

Jean Anderson Eloy1, Osamah J Choudhry, Lana D Christiano, Dare V Ajibade, James K Liu.   

Abstract

BACKGROUND: Successful reconstruction of large anterior skull base (ASB) defects after craniofacial resection of malignant skull base tumors is paramount for preventing cerebrospinal fluid (CSF) fistulas. The vascularized pedicled pericranial flap (PCF) has been the gold standard for repairing ASB defects after transbasal transcranial approaches. However, flap necrosis and delayed CSF leaks can occur after adjuvant radiation therapy. We describe a "double flap" reconstruction technique in which the PCF is augmented inferiorly by a secondary vascularized pedicled nasoseptal flap (NSF) that is harvested and rotated using an endoscopic endonasal approach.
METHODS: This technique is illustrated in 2 patients who underwent a combined cranionasal (transbasal and endoscopic endonasal) approach for large sinonasal malignancies with significant intracranial extension (1 esthesioneuroblastoma, 1 sinonasal teratocarcinosarcoma). After tumor removal via a combined cranionasal approach, primary repair of the ASB dural defect was performed with a free patch graft. The ASB defect was then repaired using the double flap technique with a vascularized PCF from above and augmented with a vascularized NSF from below.
RESULTS: Postoperatively, there were no complications of CSF leakage, meningitis, or tension pneumocephalus in both patients. After subsequent radiation therapy, the double flap repair remained intact at 2 years postoperatively in both patients.
CONCLUSION: The double flap skull base reconstruction technique provides an additional barrier of vascularized tissue to prevent CSF leakage, meningitis, tension pneumocephalus, and postradiation necrosis. This technique is a viable option if a combined transcranial and transnasal endoscopic tumor resection is performed and postoperative radiation is anticipated.
© 2013 ARS-AAOA, LLC.

Entities:  

Mesh:

Year:  2012        PMID: 23038655     DOI: 10.1002/alr.21092

Source DB:  PubMed          Journal:  Int Forum Allergy Rhinol        ISSN: 2042-6976            Impact factor:   3.858


  7 in total

1.  A novel graft material for preventing cerebrospinal fluid leakage in skull base reconstruction: technical note of perifascial areolar tissue.

Authors:  Nakamasa Hayashi; Koichi Mitsuya; Katsuya Gorai; Keita Inoue; Ichiro Ito; Masahiro Nakagawa; Yoko Nakasu
Journal:  J Neurol Surg B Skull Base       Date:  2014-08-11

2.  Hyperostotic Esthesioneuroblastoma.

Authors:  Murugappan Ramanathan; Anand V Germanwala
Journal:  J Case Rep Med       Date:  2013

3.  Sphenoid Mucocele: A Complication of Skull Base Reconstruction with Nasoseptal Flap-A Critical Review and Our Experience.

Authors:  T N Janakiram; Abhilasha Karunasagar
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2019-07-26

4.  Contemporary Trends in the Management of Posttraumatic Cerebrospinal Fluid Leaks.

Authors:  Moustafa Mourad; Jared C Inman; David M Chan; Yadranko Ducic
Journal:  Craniomaxillofac Trauma Reconstr       Date:  2016-11-01

5.  Utilization of the Nasoseptal Flap for Repair of Cerebrospinal Fluid Leak after Endoscopic Endonasal Approach for Resection of Pituitary Tumors.

Authors:  Murugappan Ramanathan; Michael Lim; Remi A Kessler; Tomas Garzon-Muvdi; Eileen Kim
Journal:  Brain Tumor Res Treat       Date:  2019-04

6.  Assessment of mucocele formation after endoscopic nasoseptal flap reconstruction of skull base defects.

Authors:  Qasim Husain; Saurin Sanghvi; Olga Kovalerchik; Pratik A Shukla; Osamah J Choudhry; James K Liu; Jean Anderson Eloy
Journal:  Allergy Rhinol (Providence)       Date:  2013

7.  Endoscopic endonasal double flap technique for reconstruction of large anterior skull base defects: technical note.

Authors:  Ricardo Landini Lutaif Dolci; Alexandre Bossi Todeschini; Américo Rubens Leite Dos Santos; Paulo Roberto Lazarini
Journal:  Braz J Otorhinolaryngol       Date:  2018-04-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.